GDRX GDRX
Company Profile ↓Company Overview
GDRX (GDRX) is a publicly traded company listed on with a market capitalization of $1.12B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 18.0% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $796.85M (+0.6% YoY); net profit $30.44M.
- Trailing 12 Months Year-on-year growth — revenue +0.6%, earnings +85.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 18.0%, profit CAGR -5.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 18.04% |
| 1 Year: | 0.57% |
Compounded Profit Growth
| 5 Years: | -5.06% |
| 1 Year: | 85.72% |
Stock Price Performance
| 1 Year: | -27.33% |
| 6 Months: | +51.39% |
| 3 Months: | +27.73% |
| 1 Month: | +7.92% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)61.24 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 18.0% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -5.1% CAGR over 5 years.
- Trading 36.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 101.75M | 133.41M | 123.30M | 140.45M | 160.43M | 176.63M | 195.10M | 203.33M | 191.80M | 187.32M | 183.99M | 189.68M | 179.96M | 197.88M | 200.61M | 195.25M | 202.97M | 203.07M | 196.03M | 194.01M |
| Operating Income | - | - | 37.84M | 43.67M | 41.74M | -61.69M | -5.00M | -351.00K | 7.00M | 19.76M | -4.05M | -15.71M | 11.30M | 18.31M | -38.33M | 7.38M | 19.88M | 20.41M | 23.38M | 26.81M | 14.62M | 14.01M |
| Net Income | 11.55M | 19.65M | 19.62M | 27.35M | 27.34M | -50.03M | 1.67M | 31.06M | -18.07M | 12.29M | -1.42M | -41.73M | -3.29M | 58.79M | -38.49M | -1.01M | 6.69M | 3.96M | 11.05M | 12.84M | 1.12M | 1.17M |
| Diluted EPS | - | - | 0.05 | 0.08 | 0.08 | -0.21 | 0.00 | 0.07 | -0.04 | 0.03 | 0.00 | -0.10 | -0.01 | 0.14 | -0.09 | 0.00 | 0.02 | 0.01 | 0.03 | 0.04 | 0.00 | 0.00 |
| R&D Expense | - | - | 7.84M | 10.32M | 11.96M | 15.85M | 26.16M | 29.57M | 35.07M | 35.04M | 35.40M | 35.92M | 32.91M | 31.29M | 39.61M | 31.02M | 30.85M | 30.14M | 31.14M | 29.93M | 31.01M | 30.18M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 249.52M | 388.22M | 550.70M | 745.42M | 766.55M | 750.26M | 792.32M | 796.85M |
| Operating Income | 77.25M | 139.68M | -275.72M | 13.41M | 1.74M | -27.01M | 65.85M | 87.49M |
| Net Income | 43.79M | 66.05M | -293.62M | -25.25M | -32.83M | -8.87M | 16.39M | 30.44M |
| Diluted EPS | 0.12 | 0.18 | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 | 0.09 |
| R&D Expense | 43.89M | 29.30M | 61.82M | 125.86M | 143.14M | 135.84M | 123.75M | 121.03M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 386.80M | 1.47B | - | 1.60B | 1.59B | 1.39B | 1.40B |
| Current Assets | - | - | - | - | - | 919.69M | 872.79M | 659.25M | 643.10M |
| Cash & Equivalents | - | 34.60M | 26.05M | 968.69M | - | 757.16M | 672.30M | 448.35M | 261.82M |
| Inventory | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | 117.14M | 143.61M | 145.93M | 235.75M |
| Total Liabilities | - | - | 737.37M | 758.75M | - | 789.80M | 826.84M | 663.41M | 787.80M |
| Current Liabilities | - | - | 33.37M | 59.55M | - | 76.32M | 122.56M | 123.90M | 246.00M |
| Long Term Debt | - | - | 663.89M | 659.89M | - | 651.80M | 647.70M | 486.71M | 483.26M |
| Total Debt | - | - | - | - | - | 717.02M | 711.07M | 543.39M | 542.81M |
| Total Equity | -31.75M | -1.16B | -1.09B | 711.36M | - | 814.83M | 761.96M | 724.66M | 616.26M |
| Shares Outstanding | - | - | - | - | - | 397.02M | 394.09M | 382.81M | 341.05M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 45.25M | 83.29M | 131.34M | 178.78M | 146.78M | 138.29M | 183.89M | 167.90M |
| Investing Cash Flow | -3.46M | -37.05M | -91.62M | -178.73M | -210.50M | -55.77M | -70.35M | -119.96M |
| Financing Cash Flow | -24.73M | -54.78M | 905.82M | -30.53M | -120.23M | -167.40M | -337.50M | -234.47M |
| Capital Expenditure | -804.00K | -1.43M | -20.55M | -4.57M | -3.97M | -1.04M | -1.24M | -3.52M |
| Free Cash Flow | 44.45M | 81.86M | 110.79M | 174.21M | 142.81M | 137.25M | 182.65M | 164.38M |
| Share Buybacks | - | - | 0 | 0 | 101.72M | 103.97M | 158.84M | 216.37M |
| Dividends Paid | 1.35B | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - |
| Operating Margin % | 31.0% | 36.0% | -50.1% | 1.8% | 0.2% | -3.6% | 8.3% | 11.0% |
| Net Margin % | 17.6% | 17.0% | -53.3% | -3.4% | -4.3% | -1.2% | 2.1% | 3.8% |
| ROE % | -3.8% | -6.1% | -41.3% | - | -4.0% | -1.2% | 2.3% | 4.9% |
| ROCE % | - | 39.5% | -19.5% | - | 0.1% | -1.8% | 5.2% | 7.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GDRX
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars - StockStory
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOODdEN2JxUlBzejViYkxkUEN5eXFZVGtHV0E2T2cyckZDMUJsMW02ZkgzRVJHdklzTlExM2JkU2RTNWRnN00xSXE0dW9QNllYcUZHalpycnhlR2s0aWtGSWVidk1pZ241elpGYW9qS0s4bTJqbmYtT2Eyellub1gxZGZMcjl4SkNlWkVLUz…
Goodrx Holdings Stock Price Forecast. Should You Buy GDRX? - StockInvest.us
<a href="https://news.google.com/rss/articles/CBMiSEFVX3lxTE1rb2F3TGZub3lyMkFKNTVGNGE1RGFRTU5WTWJOYkZoSE1ORmM0VUhrbmNBYUhMazRLSWRzSUYtbjFlejI1ZnFEMA?oc=5" target="_blank">Goodrx Holdings Stock Price Forecast. Should You Buy GDRX?</a> &…
GoodRx (GDRX) Stock Trades Up, Here Is Why - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPN2NESkluMlFsRTBKM3NUOUN5WkJkMlQ1bE9ieDdWcTJPRnZDWFBVclp4X2ZOWUdSblRwMlFVdXNYRlloSHVqMFFLWHF3RHk2SWJaUndZSEVMdTd4Z2dHa2x1bWFid3p4RFJnNktINXJyVDBHSE9IazEzakFHa1Zud0V4N2pWNnZiMUVHUG…
GDRX Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBLV2w1aGRlbm1yekZFNmdFUUx2ckVtQ2RyUHM1TmlvTnlIbXdBRGpTT0JZQnFpTGoyWmVmYmZyYVhIN0l4ZFFEV0VxdkI3cVJ6a1pXd09aa0FHV2FxZktveGJDcmlLOXVKN0J1VUhBR1otWWZ6T2hGeFVB?oc=5" target="_blank">GDR…
GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade) (NASDAQ:GDRX) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNUzF1UzVSRlRSM1VpQlo3VHViekRLOTJWaDFXZEI3bjNUNi05QllpeE1KcWJaY01VaUZhVGpWUHEwY3RiQTgzeFlaV3VPdXh2aWMwcnVnWElQaUpGVkc0QVFVRjdVVU44WnkyS19sa2J5bjBFUGh5SmpuY01nSnlqd2pvWDdzcnUtWDVodU…
GoodRx (GDRX) Stock Looks Full On Earnings But Mixed On Value - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxOM2E3NW5vY3hZNXF0bUx6cFBtMlAyN2ZsWHk1bmlhazVzRFM3ZGd2SzRQRXhaZ0JWTXJNb1V5eVU4bWZFdmlZRmNMcjdiRjlRNTVBa1V1MHNTWlVXSThvTGdkMUpXSVlYMUhoS3pmdEdZN3dXd1VSQXV0dHEtWTY3MTdSRlpKamhFcUFMVm…
GDRX — Frequently Asked Questions
What is the current share price of GDRX?
As of 2026-08-05 17:25 PDT, GDRX trades at $3.27 on NASDAQ/NYSE. Its 52-week range is $1.87 to $5.12.
What is the market capitalisation of GDRX?
GDRX has a market capitalisation of $1.12B on NASDAQ/NYSE.
What is the P/E ratio of GDRX?
GDRX trades at a trailing price-to-earnings (P/E) ratio of 36.33. Its price-to-book (P/B) ratio is 1.81.
What is the return on equity (ROE) of GDRX?
GDRX has a return on equity (ROE) of 4.94%. Its return on capital employed (ROCE) is 7.56%.
Is GDRX a good stock to buy?
This page provides a data-driven analysis of GDRX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.